Febuxostat demonstrates efficacy and renal safety in patients with gout and CKD Dr Supreeth D R23 Nov 2022 8:00 PM ISTPeiyu Zhang et al conducted a study to explore the efficacy and renal safety of febuxostat in gout and stage 2-4 chronic kidney disease (CKD) and...
Allopurinol tied to less mortality compared to febuxostat among patients with CVD Aditi4 Nov 2022 8:00 PM ISTChina: A study published in the Frontiers in Pharmacology mentioning a comparison between Allopurinol and Febuxostat has concluded that allopurinol...
Should clinicians reconsider standard therapy for gout? Isra Zaman9 July 2022 9:30 AM ISTGout occurs when urate crystals accumulate in the joints, and xanthine oxidase inhibitors such as febuxostat are a mainstay of therapy to help...
Excessive serum uric acid reduction harmful in older hyperuricaemic patients Dr. Shravani Dali14 Oct 2021 9:00 AM ISTExcessive serum uric acid (SUA) reduction may be harmful in older hyperuricaemic populations, according to a study published in the Rheumatology....
Urate lowering agents don't slow progression of CKD in hyperuricemia, finds study MD Editorial Team7 Oct 2021 10:12 PM ISTHyperuricemia is very common in CKD patients because of reduced urinary excretion of uric acid. The role of uric acid in the development CKD and...
Febuxostat has similar CV safety as Allopurinol when used in Gout: Study Dr. Shravani Dali19 July 2021 9:30 AM ISTFebuxostat used for Gout did not substantially increase the risk of cardiovascular events or death when compared to the usage of Allopurinol,...
Febuxostat initiation not associated with prolonged acute gout flares: Study Medha Baranwal4 March 2021 9:45 AM ISTChina: Febuxostat initiation during an acute gout flare does not lead to prolonged duration of acute flares, finds a recent study. According to the...
Verinurad and febuxostat protect kidney function in T2D: Study Dr Kartikeya Kohli10 Dec 2020 6:07 PM ISTResearchers at the University of Limerick, Ireland have found potential benefits of new drugs (Verinurad and febuxostat) in protecting kidney function...
Gout drug Febuxostat useful for treatment of COVID-19 Medha Baranwal16 July 2020 10:30 PM ISTIran: Febuxostat (FBX) can be used as an alternative treatment to hydroxychloroquine (HCQ) for COVID-19 patients, suggests a recent study in...
